Second quarter revenue of $13.1 million, reflecting 27% year-over-year growth
Board of Directors announces quarterly dividend of $0.06 per share
Second quarter revenue of $13.1 million, reflecting 27% year-over-year growth
Board of Directors announces quarterly dividend of $0.06 per share
80% of preliminary molecules tested exhibit submicromolar activity and acceptable ADME properties
Conference call to be on Monday, April 12, 2021, at 4:15 p.m. ET
RENAsym SAB to Provide Insights and Guidance for Development of Kidney Injury Software
Speakers from Academia, Large Pharma Collaborations and Regulatory Agencies shared their real-world impact using modeling & simulation technology
Computational Modeling, Human Liver Microphysiology Systems (MPS) and the MPS-Database Platforms to be Integrated for Safety Testing
Simulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and...
Extends reach of MonolixSuite™ to China’s growing pharmacology market
New distribution channel will accelerate adoption of software and services in emerging markets
Facilitates Access to KIWI, a Pharmacometrics Modeling and Simulation Platform
Integrated machine learning and PBPK/PD methods will support discovery and development activities
First quarter revenue of $10.7 million, reflecting 14% year-over-year growth
Board of Directors announces quarterly dividend of $0.06 per share
New modeling approaches will accelerate the evaluation of innovative formulation strategies
Conference call to be on Monday, January 11, 2021, at 4:15 p.m. ET
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals...
2020 Virtual Liver Meeting Posters Showcase Customer Applications
Brings 25 years of Financial Leadership, Significant Public Company Experience, and M&A Expertise to Company
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today reported financial results for its 2020 fiscal year (FY20) and fourth quarter (4QFY20) ended August 31, 2020.